A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer

Clinical trial NCT06319820 · RECRUITING

Trial details

NCT number: NCT06319820
Sponsor: Janssen Research & Development, LLC
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Non-Muscle Invasive Bladder Neoplasms

Start date: 2024-04-18
Primary completion: 2028-06-28
Enrollment: 641

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.